Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiebert

Showing results (881-890 of 888) with videos related to

Pageof 89
Sort By:
You have reached the last page of results.This site can display upto 888 results.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
The Journal of Infectious Diseases|December 1, 2021
Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020Jonathon D Kotwa, Alainna J Jamal, Hamza Mbareche, et al.
Journal of Medicinal Chemistry|November 23, 2020
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionLi-Qiang Sun, Eric Mull, Stanley D'Andrea, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agentYoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
Science (New York, N.Y.)|May 29, 2025
Pre-European contact leprosy in the Americas and its current persistenceMaria Lopopolo, Charlotte Avanzi, Sebastian Duchene, et al.
PLOS Global Public Health|April 9, 2025
Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in researchN Venkatesan, L Faust, R Lobo, et al.
Ecology|March 21, 2023
Extensive regional variation in the phenology of insects and their response to temperature across North AmericaPeter O Dunn, Insiyaa Ahmed, Elise Armstrong, et al.
Pageof 89

Showing results (881-890 of 888) with videos related to

Sort By:
Pageof 89
You have reached the last page of results.This site can display upto 888 results.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
The Journal of Infectious Diseases|December 1, 2021
Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020Jonathon D Kotwa, Alainna J Jamal, Hamza Mbareche, et al.
Journal of Medicinal Chemistry|November 23, 2020
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionLi-Qiang Sun, Eric Mull, Stanley D'Andrea, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agentYoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
Science (New York, N.Y.)|May 29, 2025
Pre-European contact leprosy in the Americas and its current persistenceMaria Lopopolo, Charlotte Avanzi, Sebastian Duchene, et al.
PLOS Global Public Health|April 9, 2025
Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in researchN Venkatesan, L Faust, R Lobo, et al.
Ecology|March 21, 2023
Extensive regional variation in the phenology of insects and their response to temperature across North AmericaPeter O Dunn, Insiyaa Ahmed, Elise Armstrong, et al.
Pageof 89